NEW YORK, April 28 (GenomeWeb News) - Merrill Lynch yesterday cut Waters' stock to 'Neutral' from 'Buy' after the company said first-quarter income declined year over year.
As GenomeWeb News reported, Waters on Wednesday said first-quarter sales rose 8.2 percent atop increasing R&D spending and a narrowed profit.